Back to FARALLON CAPITAL MANAGEMENT LLC

Farallon Capital Management LLC

All holdings · as of Dec 31, 2025

145 positions

CompanyClassValueShares% of portfolio
Baidu, Inc.BIDUADR$41.20M315,3000.2%
JOYY Inc.JOYYADR$37.44M578,2000.2%
ISHARES ETHEREUM TR$33.22M1,481,0010.2%
Structure Therapeutics Inc.GPCRADR$31.58M454,0000.2%
MINERALYS THERAPEUTICS INCMLYSCommon Stock$29.88M823,2960.2%
SunocoCorp LLCSUNCCommon Stock$29.88M606,2770.2%
Perceptive Capital Solutions Corp$29.32M2,250,0000.2%
Terns Pharmaceuticals, Inc.$25.94M642,0000.1%
Encompass Health Corp$24.89M234,5000.1%
Amkor Technology Inc$18.32M464,0000.1%
Verastem, Inc.$15.44M2,000,0000.1%
Doximity, Inc.$13.77M311,0000.1%
Guardant Health, Inc.$11.13M109,0000.1%
Medline Inc.$10.92M260,0000.1%
New Oriental Education & Technology Group Inc$10.79M196,0000.1%
MINERVA NEUROSCIENCES, INC.$9.51M2,365,0000.1%
GeneDx Holdings Corp.$9.10M70,0000.1%
GRAYSCALE ETHEREUM MINI TR E$6.41M228,3400.0%
Prime Medicine, Inc.PRMECommon Stock$4.31M1,240,8430.0%
Oscar Health, Inc.$3.79M264,0000.0%
MADRIGAL PHARMACEUTICALS, INC.$1.93M3,3190.0%
Summit Midstream Corp$1.55M58,2140.0%
Novavax Inc$1.31M195,0000.0%
Schrodinger, Inc.$1.27M71,0000.0%
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVAADR$1.25M40,0000.0%
CAPRICOR THERAPEUTICS, INC.$1.18M41,0000.0%
ARROWHEAD PHARMACEUTICALS, INC.$1.05M15,8000.0%
ALVOTECH$1.02M199,6750.0%
BrightSpring Health Services, Inc.$823.9K22,0000.0%
Roivant Sciences Ltd.$802.9K37,0000.0%
Arcutis Biotherapeutics, Inc.$755.0K26,0000.0%
Axsome Therapeutics, Inc.$730.6K4,0000.0%
Cogent Biosciences, Inc.$603.8K17,0000.0%
Alkermes plc.$582.0K20,8000.0%
INSMED INC$522.1K3,0000.0%
Krystal Biotech, Inc.$493.1K2,0000.0%
Progyny, Inc.$462.2K18,0000.0%
Travere Therapeutics, Inc.$458.5K12,0000.0%
HEALTHEQUITY, INC.$458.1K5,0000.0%
Celcuity Inc.CELCCommon Stock$399.0K4,0000.0%
OMEROS CORP$395.0K23,0000.0%
IONIS PHARMACEUTICALS INC$379.7K4,8000.0%
LivaNova PLC$369.2K6,0000.0%
Globus Medical Inc$349.2K4,0000.0%
Cencora Inc$337.8K1,0000.0%
UNIQURE NV$335.0K14,0000.0%
BeOne Medicines Ltd.ONCADR$334.2K1,1000.0%
CG Oncology, Inc.$332.2K8,0000.0%
Scholar Rock Holding Corp$308.4K7,0000.0%
Immunovant, Inc.IMVTCommon Stock$305.0K12,0000.0%
← PrevPage 2 of 3Next →